Bilimsel çalışmalar

Prof. Dr. Halil Taşkaynatan

62 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103979 PMID 42194940 Açık erişimli tam metinKaynak: OpenAlex

  2. The RATAB Framework: An Interpretable AI-Driven Radiographic Risk Stratification Model for Suspected Lung Lesions

    Journal of Imaging Informatics in Medicine, 2026

    DOI 10.1007/s10278-026-02303-5 PMID 42768277 Kaynak: OpenAlex

  3. KIM-1 immunohistochemistry and early ccRCC recurrence outside adjuvant eligibility criteria: a two-centre exploratory study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-17191-9 Açık erişimli tam metinKaynak: OpenAlex

  4. Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma

    Tumori Journal, 2026

    DOI 10.1177/03008916251410475 PMID 41568754 Kaynak: ORCID

  5. Immunoscore and Post-Neoadjuvant Pathological Features in Microsatellite-Stable Locally Advanced Gastric Cancer: A Retrospective Cohort Study

    Cancers, 2026

    DOI 10.3390/cancers18203329 PMID 42938863 Açık erişimli tam metinKaynak: ORCID

  6. Pretreatment Claudin-18.2 Expression Predicts Poorer Survival Outcomes in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy

    Diagnostics, 2026

    DOI 10.3390/diagnostics16091277 PMID 42121981 Açık erişimli tam metinKaynak: ORCID

  7. Association of Abdominal Aortic Calcification with Pathological Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Retrospective Exploratory Study

    Asian Pacific journal of cancer prevention : APJCP, 2026

    DOI 10.31557/apjcp.2026.27.10.3723 PMID 42935064 Açık erişimli tam metinKaynak: Europe PMC

  8. Leveraging the non-contrast CT component of PET/CT: an AI-driven delta-radiomics approach to monitor treatment response in metastatic breast cancer

    BMC Medical Imaging, 2026

    DOI 10.1186/s12880-026-02463-4 PMID 42185986 Açık erişimli tam metinKaynak: OpenAlex

  9. Pretreatment Hemoglobin, Albumin, Lymphocyte, and Platelet Score Predicts Pathological Response and Postoperative Pathological Findings in Locally Advanced Gastric Cancer

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-5-2 Açık erişimli tam metinKaynak: OpenAlex

  10. Cumulative chemotherapy exposure and social isolation as correlates of caregiver burden and anxiety among family caregivers in outpatient oncology: a cross-sectional study

    Research Square, 2026

    DOI 10.21203/rs.3.rs-11062964/v1 Açık erişimli tam metinKaynak: OpenAlex

  11. A multi-center case-control study on osteoporosis risk in cancer patients receiving chemotherapy.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.12033 Kaynak: OpenAlex

  12. A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09973-x PMID 41225034 1 atıf (Europe PMC) Kaynak: OpenAlex

  13. Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making

    Diagnostics, 2025

    DOI 10.3390/diagnostics15243163 PMID 41464164 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  14. Prevalence of Insomnia and Associated Factors in Female Patients Undergoing Chemotherapy

    Nature and science of sleep, 2025

    DOI 10.2147/nss.s554960 PMID 41084526 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  15. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  16. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1104_21 PMID 36510987 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  17. Gebelikte Onkolojik Yaklaşımlar

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1656 Kaynak: OpenAlex

  18. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

    Anti-Cancer Drugs, 2022

    DOI 10.1097/cad.0000000000001310 PMID 35703239 3 atıf (Europe PMC) Kaynak: OpenAlex

  19. Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer

    Bratislavské lekárske listy/Bratislava medical journal, 2022

    DOI 10.4149/bll_2022_063 PMID 35576541 6 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  20. Onkolojide Palyatif Bakım ve Yaşam Sonu Desteği

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1755 Kaynak: OpenAlex

  21. Immunotherapy-induced granulomatous reaction in patients with melanoma

    Melanoma Research, 2022

    DOI 10.1097/cmr.0000000000000815 PMID 35752875 2 atıf (OpenAlex) Kaynak: OpenAlex

  22. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study

    Journal of Cancer Research and Clinical Oncology, 2021

    DOI 10.1007/s00432-020-03501-6 PMID 33433657 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  23. Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

    International Journal of Clinical Oncology, 2021

    DOI 10.1007/s10147-021-01936-6 PMID 34023933 14 atıf (Europe PMC) Kaynak: ORCID

  24. Neuroendocrine Differentiated Breast Cancer Cases: A Retrospective Analysis and Literature Review

    Sisli Etfal Hastanesi tip bulteni, 2021

    DOI 10.14744/semb.2021.66503 PMID 35317367 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  25. Capecitabine suppresses seizure activity in rats with pentylenetetrazol-induced epilepsy

    The Annals of Clinical and Analytical Medicine, 2021

    DOI 10.4328/acam.20407 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  26. PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY)

    AYBU AVESIS, 2020

    Kaynak: OpenAlex

  27. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

    European Urology Focus, 2020

    DOI 10.1016/j.euf.2020.09.010 PMID 33008789 8 atıf (Europe PMC) Kaynak: ORCID

  28. Opere Over Kanseri Hastalarında Preoperatif Yüksek CA125 Değerinin Postoperatif Normal Sınırlara Dönmesinin Klinik Önemi

    Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 2020

    DOI 10.34087/cbusbed.743230 Kaynak: ORCID

  29. Preliminary study of serum Galectin-1 in breast cancer carcinogenesis [Izmir Oncology Group (IZOG) study].

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2020

    PMID 32521852 4 atıf (Europe PMC) Kaynak: ORCID

  30. Prognostic role of De Ritis and basal neutrophil to lymphocyte ratio in patients with advanced stage pancreatic cancer [Izmir Oncology Group (IZOG) Study].

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2020

    PMID 32521907 2 atıf (Europe PMC) Kaynak: ORCID

  31. Chemotherapy-induced sarcopenia in newly diagnosed cancer patients: Izmir Oncology Group (IZOG) study

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020

    DOI 10.1007/s00520-019-05165-6 PMID 31758325 13 atıf (Europe PMC) Kaynak: ORCID

  32. Prognostic value of De Ritis ratio (aspartate transaminase/alanine transaminase) in patients with non-metastatic colorectal carcinoma [izmir oncology group(IZOG) study].

    Journal of Clinical Oncology, 2020

    DOI 10.1200/jco.2020.38.15_suppl.e16114 Kaynak: ORCID

  33. The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study)

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020

    DOI 10.1007/s00520-020-05477-y PMID 32335732 20 atıf (Europe PMC) Kaynak: ORCID

  34. Low dose (d1-5/7) oral etoposide regimen in intensively treated platinum-resistant epithelial ovarian cancer: The Izmir oncology group (IZOG) study

    Annals of Medical Research, 2020

    DOI 10.5455/annalsmedres.2019.12.862 Açık erişimli tam metinKaynak: OpenAlex

  35. Prognostic role of pretreatment de ritis and neutrophil to lymphocyte ratio in neuroendocrine carcinoma patients (Izmir oncology group study)

    Annals of Medical Research, 2020

    DOI 10.5455/annalsmedres.2020.01.057 Açık erişimli tam metinKaynak: OpenAlex

  36. Prognostic Value of De-Ritis Ratio in Adolescents and Young Adult Patients with Breast Cancer

    Acta Oncol Tur., 2020

    DOI 10.5505/aot.2020.85619 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  37. An analysis of adjuvant treatment strategies in operated pancreatic cancer patients: An Izmir oncology group study

    Indian Journal of Cancer, 2020

    DOI 10.4103/ijc.ijc_318_18 PMID 32445318 1 atıf (OpenAlex) Kaynak: OpenAlex

  38. The clinicopathological significance of basal markers in early-stage invasive carcinoma of no special type of the breast

    Turkish Journal of Pathology, 2020

    DOI 10.5146/tjpath.2020.01487 PMID 32364614 Açık erişimli tam metinKaynak: OpenAlex

  39. Hepatosellüler Kanser Tanılı Hastalarda Trombosit Lenfosit Orani’nin Tümör Morfolojisi ve Alfa Fetoprotein ile İlişkisi

    Turkish Journal of Family Medicine & Primary Care, 2020

    DOI 10.21763/tjfmpc.659799 Açık erişimli tam metinKaynak: OpenAlex

  40. Three Case Reports with Inoperable Mesenteric Desmoid Tumors

    Acta Oncologica Turcica, 2019

    DOI 10.5505/aot.2019.07078 Açık erişimli tam metinKaynak: ORCID

  41. Prevalence and related factors of sarcopenia in newly diagnosed cancer patients

    Supportive Care in Cancer, 2019

    DOI 10.1007/s00520-019-04880-4 PMID 31161438 29 atıf (OpenAlex) Kaynak: OpenAlex

  42. High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis.

    PubMed, 2019

    PMID 31646807 15 atıf (OpenAlex) Kaynak: OpenAlex

  43. Effect of diabetes mellitus on prognosis and development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

    Annals of Medical Research, 2019

    DOI 10.5455/annalsmedres.2019.07.440 Açık erişimli tam metinKaynak: OpenAlex

  44. Evaluation of efficacy and toxicity of anthracycline plus cyclophosphamide every three weeks followed by weekly paclitaxel: The Izmır Oncology Group (IZOG) Study

    Acta Oncologica Turcica, 2019

    DOI 10.5505/aot.2019.05668 Açık erişimli tam metinKaynak: OpenAlex

  45. Tedavi Dirençli Metastatik Kolorektal Kanser TanılıHastalarda Raltitrexed Tedavisinin Etkinliği veGüvenirliliği

    2019

    Kaynak: OpenAlex

  46. The role of FOLFOXIRI in chemorefractory metastatic colorectal cancer patients

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.03.001 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  47. Ki-67 Labeling Index in Patients with Estrogen-Progesterone Positive and Axillary Lymph Node Negative Breast Cancer

    Konuralp Tıp Dergisi, 2018

    DOI 10.18521/ktd.430081 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  48. Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancer

    Polish Journal of Pathology, 2018

    DOI 10.5114/pjp.2018.76699 PMID 30351863 22 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  49. Is adjuvant chemotherapy necessary for Luminal A-like breast cancer?

    PubMed, 2018

    PMID 30358189 5 atıf (OpenAlex) Kaynak: OpenAlex

  50. Prognostic Significance of Immunohistochemical P53 Expression in Patients with Breast Cancer

    Acta Oncologica Turcica, 2018

    DOI 10.5505/aot.2018.55264 Açık erişimli tam metinKaynak: OpenAlex